IR情報

2018/08/21~2019/01/21

IR情報&株価推移

日付始値高値安値終値前日比出来高時価総額25日乖離
2019
01/211,8631,8771,8581,865+1.03%498,9003691億8366万+3.32%
01/181,8291,8601,8201,846+1.15%717,8003654億2254万+2.21%
01/171,8521,8531,8241,825-0.22%696,6003612億6551万+0.88%
01/161,8591,8621,8231,829-0.81%636,3003620億5733万+0.88%
01/151,8141,8541,8131,844+1.04%898,4003650億2663万+1.43%
01/111,8011,8291,8001,825+1.61%844,2003612億6551万+0.05%
01/101,8001,8031,7771,796-1.64%1,888,1003555億2485万-1.8%
01/091,8101,8281,7801,826+0.61%1,322,7003614億6346万-0.49%
01/081,8141,8421,7911,815-0.17%2,062,0003592億8597万-1.36%
01/071,8021,8321,7941,818+3.89%1,270,3003598億7983万-1.46%
01/041,7181,7621,7111,750-0.4%1,209,1003464億1898万-5.41%
2018
12/281,7521,7721,7421,757+1.09%997,5003478億466万-5.39%
12/271,7381,7491,7181,738+3.02%1,254,2003440億4354万-6.76%
12/261,6781,6991,6591,687+1.87%1,131,0003339億4790万-9.83%
12/251,6891,6921,6521,656-3.66%1,640,8003278億1133万-11.96%
12/211,7481,7551,7111,719-1.94%1,618,9003402億8242万-9.1%
12/201,7881,7911,7471,753-2.5%1,584,2003470億1284万-7.74%
12/191,8121,8121,7881,798-1.21%1,310,2003559億2076万-5.72%
12/181,8011,8231,7941,820-1.14%2,073,3003602億7574万-4.86%
12/171,8491,8611,8411,841-0.49%1,116,5003644億3277万-4.01%
12/141,8641,8851,8471,850-1.75%1,546,0003662億1435万-3.75%
12/131,8671,8951,8611,883+1.18%1,203,3003727億4683万-2.23%
12/121,8521,8661,8451,861+1.14%903,3003683億9184万-3.53%
12/111,8691,8691,8241,840-1.76%1,545,6003642億3482万-4.76%
12/101,8741,8751,8591,873-1.47%871,5003707億6729万-3.3%
12/071,9201,9311,8911,901-0.68%1,054,9003763億999万-2.11%
12/061,9191,9191,8951,914-0.83%1,260,6003788億8339万-1.59%
12/051,9151,9391,9041,930-0.87%1,229,0003820億5065万-0.87%
12/041,9801,9821,9421,947-2.16%1,511,7003854億1586万0%
12/031,9832,0001,9811,990+1.53%1,007,5003939億2787万+2.26%
11/301,9361,9641,9201,960+0.2%1,720,9003879億8926万+0.82%
11/291,9581,9741,9551,956+0.72%943,0003871億9745万+0.72%
11/281,9401,9451,9251,942-0.21%929,0003844億2609万-0.05%
11/271,9351,9531,9321,946+0.46%1,006,0003852億1791万+0.05%
11/261,9241,9431,9171,937-0.05%823,0003834億3633万-0.56%
11/221,9361,9551,9261,938+1.04%1,147,2003836億3428万-0.67%
11/211,9001,9251,8981,918-0.36%866,2003796億7521万-1.89%
11/201,9041,9301,9001,925+0.42%980,7003810億6088万-1.79%
11/191,9151,9211,9081,917-0.26%837,1003794億7725万-2.44%
11/161,9271,9411,9171,922-0.88%953,4003804億6702万-2.39%
11/151,9151,9441,9121,939+0.41%894,8003838億3223万-1.77%
11/141,9331,9431,9251,931-0.21%904,2003822億4860万-2.47%
11/131,9251,9411,9161,935-0.97%1,393,4003830億4042万-2.67%
11/121,9441,9631,9431,954+0.26%800,8003868億154万-2.1%
11/091,9291,9581,9211,949+0.21%897,8003858億1177万-2.74%
11/081,9711,9861,9411,945-0.05%1,107,4003850億1996万-3.43%
11/071,9591,9741,9401,946-0.41%1,484,0003852億1791万-3.9%
11/061,9311,9831,9311,954-0.05%1,813,5003868億154万-4.07%
11/0511:30 2018年度第2四半期決算及び業績見通し説明資料
11/0511:30 2019年3月期第2四半期決算短信[日本基準](連結)
11/051,9782,0111,9111,955-2.3%2,724,3003869億9949万-4.45%
11/021,9892,0071,9792,001+1.16%1,524,9003961億536万-2.63%
11/0116:00 2018年満期ユーロ円建取得条項付転換社債型新株予約権付社債および2021年満期ユーロ円建取得条項付転換社債型新株予約権付社債の転換価額の調整に関するお知らせ
11/0116:00 剰余金の配当(中間配当)に関するお知らせ
11/011,9581,9881,9471,978+0.92%1,039,2003915億5243万-4.03%
10/311,9271,9641,9171,960+1.4%1,096,2003879億8926万-5.18%
10/301,8901,9431,8831,933+0.57%2,102,6003826億4451万-7.02%
10/291,9511,9671,9191,922-0.47%889,4003804億6702万-8.08%
10/261,9431,9621,9141,931+0.36%1,318,0003822億4860万-8.14%
10/251,9331,9371,9161,924-2.83%1,511,0003808億6293万-8.94%
10/241,9911,9951,9681,980+0.1%943,0003919億4833万-6.82%
10/232,0162,0241,9741,978-2.47%1,290,2003915億5243万-7.22%
10/221,9962,0361,9882,028+0.9%912,9004014億5011万-5.19%
10/192,0102,0131,9922,010-0.99%1,210,6003978億8695万-6.12%
10/182,0402,0542,0252,030-1.12%860,6004018億4602万-5.36%
10/172,0652,0722,0462,053+0.34%1,183,1004063億9896万-4.42%
10/162,0302,0512,0262,046+0.79%1,153,4004050億1328万-4.88%
10/152,0402,0522,0212,030-0.98%1,020,9004018億4602万-5.76%
10/122,0362,0522,0242,050-0.73%1,076,0004058億509万-4.96%
10/112,0852,0982,0522,065-3.19%1,655,4004087億7440万-4.4%
10/102,1502,1602,1182,133-0.05%1,191,9004222億3525万-1.43%
10/092,1312,1462,1162,134-1.11%1,200,2004224億3321万-1.52%
10/052,1922,2002,1552,158-2.26%1,299,4004271億8409万-0.51%
10/042,2212,2312,2062,208-0.27%773,8004370億8178万+1.7%
10/032,2242,2412,2062,214-1.12%1,163,8004382億6950万+1.93%
10/022,2122,2462,2122,239+2.28%1,516,1004432億1834万+3.08%
10/012,1802,1982,1692,189+0.46%735,7004333億2066万+0.83%
09/282,1612,1892,1592,179+1.59%1,412,3004313億4112万+0.32%
09/2710:30 当社保有のキョーリン製薬ホールディングス株式売却のお知らせ
09/272,1382,1552,1342,145+0.28%1,252,5004246億1070万-1.29%
09/262,1752,1822,1272,139-5.14%2,769,4004234億2297万-1.56%
09/252,2472,2572,2172,255+0.58%1,160,6004463億8560万+3.73%
09/212,1982,2422,1972,242+2.42%1,626,8004438億1221万+3.32%
09/202,2152,2152,1792,189-1.08%1,156,0004333億2066万+1.11%
09/192,2322,2402,2102,213+0.05%759,7004380億7155万+2.31%
09/182,1862,2272,1822,212+1.84%1,195,0004378億7359万+2.41%
09/142,1812,1812,1512,172+1.92%1,350,7004299億5545万+0.79%
09/132,1072,1342,1062,131+1.77%848,7004218億3934万-1.11%
09/122,1042,1112,0852,094-0.24%882,7004145億1506万-2.88%
09/112,1112,1122,0922,099-0.57%897,7004155億483万-2.78%
09/102,1262,1302,1102,111-1.17%809,3004178億8027万-2.4%
09/0714:00 高尿酸血症・痛風治療剤「フェブリク」再審査期間延長の通知発出について
09/072,1352,1452,1192,136+1.04%1,481,3004228億2911万-1.34%
09/062,1152,1352,1072,114-0.05%806,0004184億7413万-2.49%
09/052,1132,1242,1012,115-0.38%995,3004186億7209万-2.58%
09/042,1422,1482,1142,123-1.53%1,219,3004202億5571万-2.35%
09/032,1902,1932,1432,156-2.04%824,8004267億8819万-0.78%
08/312,1802,2112,1752,201+0.05%808,6004356億9610万+1.43%
08/302,1962,2022,1862,200+0.18%935,3004354億9815万+1.62%
08/292,2162,2192,1952,196-1.44%1,384,3004347億634万+1.67%
08/282,2392,2542,2282,228+0.04%813,7004410億4085万+3.44%
08/272,2292,2372,2162,227+0.27%741,7004408億4290万+3.77%
08/242,2212,2272,2102,221+0.95%701,5004396億5518万+3.88%
08/232,2002,2102,1902,2000%774,3004354億9815万+3.24%
08/222,1772,2002,1692,200+2.09%971,6004354億9815万+3.58%
08/212,1532,1592,1312,155-0.32%634,0004265億9023万+1.75%